{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:46:16Z","timestamp":1790289976910,"version":"4.1.0"},"reference-count":50,"publisher":"BMJ","issue":"3","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2019,10,17]]},"published-print":{"date-parts":[[2020,2]]},"abstract":"<jats:p>Cardiovascular magnetic resonance (CMR) is a rapidly evolving non-invasive imaging modality offering comprehensive, multiparametric assessment of cardiac structure and function in a variety of clinical situations. Cine imaging with CMR is the gold standard non-invasive imaging technique for the quantification of ventricular volumes and systolic function. It also affords superior visualisation of apical and right ventricular morphological abnormalities. In coronary artery disease, CMR stress perfusion imaging identifies functionally significant coronary artery disease with high sensitivity and specificity, and international guidelines recommend CMR perfusion imaging in patients with chest pain at intermediate-high risk of coronary disease. Late gadolinium enhancement (LGE) imaging is the most sensitive imaging technique for identifying infarction\/viability. In non-ischaemic cardiomyopathy, LGE imaging plays vital diagnostic and prognostic roles in a number of cardiomyopathies (eg, hypertrophic and dilated cardiomyopathies, and amyloidosis). In vivo tissue characterisation with CMR enables the identification of oedema\/inflammation in acute coronary syndromes\/myocarditis and the diagnosis of chronic fibrotic conditions (eg, in hypertrophic and dilated cardiomyopathy, aortic stenosis and amyloidosis). CMR T2* imaging uniquely offers non-invasive assessment of iron overload states, facilitating diagnosis and management. A multiparametric CMR approach also enables differentiation of cardiac masses\/tumours and is a useful adjunct to echocardiography in the assessment of valve disease. The emergence of automated, inline, quantitative methodologies will expand the scope of CMR and reduce its cost in forthcoming years.<\/jats:p>","DOI":"10.1136\/heartjnl-2019-314856","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T17:25:20Z","timestamp":1576085120000},"page":"174-181","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":79,"title":["Cardiovascular magnetic resonance: applications and practical considerations for the general cardiologist"],"prefix":"10.1136","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4533-8374","authenticated-orcid":false,"given":"Jayanth Ranjit","family":"Arnold","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry P","family":"McCann","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Sciences, University of Leicester, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"2025092002005359000_106.3.174.1","doi-asserted-by":"crossref","unstructured":"Ridgway JP . Cardiovascular magnetic resonance physics for clinicians: part I. J Cardiovasc Magn Reson 2010;12.doi:10.1186\/1532-429X-12-71","DOI":"10.1186\/1532-429X-12-71"},{"key":"2025092002005359000_106.3.174.2","doi-asserted-by":"crossref","unstructured":"Biglands JD , Radjenovic A , Ridgway JP . Cardiovascular magnetic resonance physics for clinicians: Part II. J Cardiovasc Magn Reson 2012;14.doi:10.1186\/1532-429X-14-66","DOI":"10.1186\/1532-429X-14-66"},{"key":"2025092002005359000_106.3.174.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603265"},{"key":"2025092002005359000_106.3.174.4","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.155.3.4001369"},{"key":"2025092002005359000_106.3.174.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.12.061"},{"key":"2025092002005359000_106.3.174.6","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2017162740"},{"key":"2025092002005359000_106.3.174.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-004-2583-y"},{"key":"2025092002005359000_106.3.174.8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00062-018-0678-0","article-title":"A review of the current evidence on gadolinium deposition in the brain","volume":"28","author":"Pullicino","year":"2018","journal-title":"Clin Neuroradiol"},{"key":"2025092002005359000_106.3.174.9","doi-asserted-by":"publisher","DOI":"10.1053\/euhj.2000.2011"},{"key":"2025092002005359000_106.3.174.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.11.048"},{"key":"2025092002005359000_106.3.174.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.10.040"},{"key":"2025092002005359000_106.3.174.12","doi-asserted-by":"crossref","unstructured":"Mangion K , McComb C , Auger DA , et al . Magnetic resonance imaging of myocardial strain after acute ST-Segment\u2013Elevation myocardial infarction. Circulation 2017;10.doi:10.1161\/CIRCIMAGING.117.006498","DOI":"10.1161\/CIRCIMAGING.117.006498"},{"key":"2025092002005359000_106.3.174.13","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.507723"},{"key":"2025092002005359000_106.3.174.14","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq025"},{"key":"2025092002005359000_106.3.174.15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12389-6"},{"key":"2025092002005359000_106.3.174.16","doi-asserted-by":"crossref","unstructured":"Muehlberg F , Arnhold K , Fritschi S , et al . Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy \u2013 a prospective clinical cardiovascular magnetic resonance trial. J Cardiovasc Magn Reson 2018;20.doi:10.1186\/s12968-018-0434-2","DOI":"10.1186\/s12968-018-0434-2"},{"key":"2025092002005359000_106.3.174.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200011163432003"},{"key":"2025092002005359000_106.3.174.18","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11110228"},{"key":"2025092002005359000_106.3.174.19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4330\/wjc.v9.i2.109","article-title":"Cardiovascular magnetic resonance imaging assessment of outcomes in acute myocardial infarction","volume":"9","author":"Khan","year":"2017","journal-title":"World J Cardiol"},{"key":"2025092002005359000_106.3.174.20","doi-asserted-by":"crossref","unstructured":"Mather AN , Lockie T , Nagel E , et al . Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. Journal of Cardiovascular Magnetic Resonance 2009;11.doi:10.1186\/1532-429X-11-33","DOI":"10.1186\/1532-429X-11-33"},{"key":"2025092002005359000_106.3.174.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2005.08.021"},{"key":"2025092002005359000_106.3.174.22","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.205542"},{"key":"2025092002005359000_106.3.174.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.08.064"},{"key":"2025092002005359000_106.3.174.24","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2015-307682"},{"key":"2025092002005359000_106.3.174.25","doi-asserted-by":"publisher","DOI":"10.1080\/10976640600605002"},{"key":"2025092002005359000_106.3.174.26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.016567"},{"key":"2025092002005359000_106.3.174.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2016.05.009"},{"key":"2025092002005359000_106.3.174.28","doi-asserted-by":"crossref","unstructured":"Bruder O , Wagner A , Lombardi M , et al . European cardiovascular magnetic resonance (EuroCMR) registry \u2013 multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson 2013;15.doi:10.1186\/1532-429X-15-9","DOI":"10.1186\/1532-429X-15-S1-O96"},{"key":"2025092002005359000_106.3.174.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.10.007"},{"key":"2025092002005359000_106.3.174.30","unstructured":"Knuuti J , Wijns W , Saraste A , et al . 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2019."},{"key":"2025092002005359000_106.3.174.31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0140-6736(11)61335-4","article-title":"Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial","volume":"379","author":"Greenwood","year":"2012","journal-title":"The Lancet"},{"key":"2025092002005359000_106.3.174.32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehm617"},{"key":"2025092002005359000_106.3.174.33","doi-asserted-by":"crossref","unstructured":"Takx RAP , Blomberg BA , Aidi HE , El Aidi H , et al . Diagnostic accuracy of stress myocardial perfusion imaging compared to invasive coronary angiography with fractional flow reserve meta-analysis. Circulation 2015;8.doi:10.1161\/CIRCIMAGING.114.002666","DOI":"10.1161\/CIRCIMAGING.114.002666"},{"key":"2025092002005359000_106.3.174.34","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1056\/NEJMoa1716734","article-title":"Magnetic resonance perfusion or fractional flow reserve in coronary disease","volume":"380","author":"Nagel","year":"2019","journal-title":"N Engl J Med"},{"key":"2025092002005359000_106.3.174.35","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.12680"},{"key":"2025092002005359000_106.3.174.36","doi-asserted-by":"publisher","DOI":"10.1097\/RTI.0000000000000077"},{"key":"2025092002005359000_106.3.174.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.09.072"},{"key":"2025092002005359000_106.3.174.38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.10.065"},{"key":"2025092002005359000_106.3.174.39","first-page":"392","article-title":"Identification and assessment of Anderson-Fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","volume":"6","author":"Sado","year":"2013","journal-title":"Circulation"},{"key":"2025092002005359000_106.3.174.40","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.874487"},{"key":"2025092002005359000_106.3.174.41","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia","volume":"360","author":"Anderson","year":"2002","journal-title":"The Lancet"},{"key":"2025092002005359000_106.3.174.42","doi-asserted-by":"crossref","unstructured":"Schelbert EB , Sabbah HN , Butler J , et al . Employing extracellular volume cardiovascular magnetic resonance measures of myocardial fibrosis to foster novel therapeutics. Circulation 2017;10.doi:10.1161\/CIRCIMAGING.116.005619","DOI":"10.1161\/CIRCIMAGING.116.005619"},{"key":"2025092002005359000_106.3.174.43","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.13121239"},{"key":"2025092002005359000_106.3.174.44","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-017-0238-0","article-title":"Cardiovascular magnetic resonance in the evaluation of heart valve disease","volume":"17","author":"Gulsin","year":"2017","journal-title":"BMC Med Imaging"},{"key":"2025092002005359000_106.3.174.45","doi-asserted-by":"crossref","unstructured":"Myerson SG . Heart valve disease: investigation by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2012;14.doi:10.1186\/1532-429X-14-7","DOI":"10.1186\/1532-429X-14-7"},{"key":"2025092002005359000_106.3.174.46","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.echo.2018.04.006","article-title":"A comparative assessment of echocardiographic parameters for determining primary mitral regurgitation severity using magnetic resonance imaging as a reference standard","volume":"31","author":"Uretsky","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"2025092002005359000_106.3.174.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2014.04.021"},{"key":"2025092002005359000_106.3.174.48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10554-017-1225-9","article-title":"Fully-automated left ventricular mass and volume MRI analysis in the UK Biobank population cohort: evaluation of initial results","volume":"34","author":"Suinesiaputra","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"2025092002005359000_106.3.174.49","doi-asserted-by":"crossref","unstructured":"Kellman P , Hansen MS , Nielles-Vallespin S , et al . Myocardial perfusion cardiovascular magnetic resonance: optimized dual sequence and reconstruction for quantification. J Cardiovasc Magn Reson 2017;19.doi:10.1186\/s12968-017-0355-5","DOI":"10.1186\/s12968-017-0355-5"},{"key":"2025092002005359000_106.3.174.50","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.024919"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2019-314856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:01:04Z","timestamp":1758358864000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2019-314856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,1,8]]},"published-print":{"date-parts":[[2020,2]]}},"alternative-id":["10.1136\/heartjnl-2019-314856"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2019-314856","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]}}}